# Safety & Tolerability of a Combination of Antidepressant and Peptic Ulcer Drug in Overweight Healthy Subjects

> **NCT01155531** · PHASE1 · COMPLETED · sponsor: **Theracos** · enrollment: 40 (actual)

## Conditions studied

- Obesity

## Interventions

- **DRUG:** Sertraline plus Telenzepine

## Key facts

- **NCT ID:** NCT01155531
- **Lead sponsor:** Theracos
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-05
- **Primary completion:** 2010-08
- **Final completion:** 2010-08
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2019-06-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01155531

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01155531, "Safety & Tolerability of a Combination of Antidepressant and Peptic Ulcer Drug in Overweight Healthy Subjects". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01155531. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*